Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-25-000005
Filing Date
2025-01-02
Accepted
2025-01-02 15:39:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3410
  Complete submission text file 0001971857-25-000005.txt   4963
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Subject) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-33216 | Film No.: 25501829
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1018 HARTZELL ST PACIFIC PALISADES CA 90272
Business Address
Gottfurcht Grant (Reporting) CIK: 0002034802 (see all company filings)

Type: 144